Summary
Boston Scientific Corporation (BSX) filed a Form 8-K on July 26, 2004, primarily to furnish a press release announcing its financial results for the second quarter ended June 30, 2004. This filing indicates the company is providing updated financial performance information to investors, as is standard practice. The press release, attached as Exhibit 99.1, contains the detailed financial results and management commentary. Investors should review this press release for specifics regarding revenue, profitability, and any forward-looking statements or strategic updates. While the 8-K itself is brief, its core purpose is to make the Q2 2004 financial results publicly available and digestible for the investment community. The filing emphasizes that the information furnished is not deemed "filed" for certain SEC liability purposes, but it serves as the official announcement of the company's financial standing for the period. Investors interested in BSX's performance trends, operational highlights, or any challenges encountered in the second quarter should consult the accompanying press release.
Key Highlights
- 1Boston Scientific Corporation (BSX) filed an 8-K on July 26, 2004.
- 2The filing's primary purpose is to announce the company's financial results for the second quarter ended June 30, 2004.
- 3A press release, dated July 26, 2004, detailing the Q2 2004 financial results is included as Exhibit 99.1.
- 4Investors are directed to the press release for specific financial performance data and commentary.
- 5The information furnished in the 8-K and exhibit is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934.
- 6This report serves as an official update on the company's financial condition and results of operations for the second quarter.